Please select the option that best describes you:
Topics:
Genitourinary Cancers • Prostate Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Duke • NCI-CCC GU Tumor Board Question • Duke GU Tumor Board
How do you approach imaging in patients with M0 castration-resistant prostate cancer with rising PSA on an ARSI?
What imaging modality do you use (conventional, PSMA PET, etc.)? When do you image (ex: a PSA threshold or PSADT)?
Answer from: Medical Oncologist at Academic Institution
I do not use molecular imaging (e.g., PSMA-PET/CT) for patients with CRPC (including both mCRPC and nmCRPC) except as a screening tool for Pluvicto eligibility for three reasons.
Most patients have metastasis already. In one study that used molecular imaging in patients with nmCRPC, they identified...
Sign in or Register to read more